Announcements Trials
Browse Landscape

Phase

Phase 2 7Phase EARLY_PHASE1 3Phase 3 3Phase NA 2Phase 1 2Phase 4 1

Status

Completed 2Terminated 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 3

Conditions

Pancreatic Neoplasms 1Colorectal Neoplasia 1Barrett Esophagus 1

Interventions

Magnetic Resonance Spectroscopy 59Cyclophosphamide 44pembrolizumab 34Radiotherapy 30fludarabine 27Nivolumab 26Biopsy 26Metformin 22Fluorodeoxyglucose F18 22Specimen Handling 20Bevacizumab 20Temozolomide 17Radiosurgery 17Cisplatin 16Carboplatin 14Fluorouracil 13Dexamethasone 13Paclitaxel 12Gemcitabine 12Etoposide 12gallium 68 PSMA-11 11durvalumab 11X-Rays 11Surgical Procedures, Operative 11Radiation 11Positron Emission Tomography Computed Tomography 11Letrozole 11Irinotecan 11Ipilimumab 11Surveys and Questionnaires 10

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × OTHER × Omeprazole × Clear all
NCT04930991 2026-06-01

OU202005AJ

University of Oklahoma

Phase EARLY_PHASE1 Terminated
25 enrolled
Gastrointestinal

Pancreatic Neoplasms

NCT06378398 2026-03-13

A Trial of Omeprazole and Low Dose Aspirin to Identify Colorectal Biomarkers of Preventive Efficacy

University of Michigan Rogel Cancer Center

Phase EARLY_PHASE1 Completed
21 enrolled
Gastrointestinal

Colorectal Neoplasia

NCT01465113 2016-03-10

Vitamin D Supplementation on 15-Prostaglandin Dehydrogenase Expression in Barrett's Esophagus

Case Comprehensive Cancer Center

Phase EARLY_PHASE1 Completed
26 enrolled
Gastrointestinal

Barrett Esophagus

Data powered by HemOnc (CC BY 4.0) Colophon âš¡